376 related articles for article (PubMed ID: 28591133)
21. Non-estrogen conventional and phytochemical treatments for vasomotor symptoms: what needs to be known for practice.
Villaseca P
Climacteric; 2012 Apr; 15(2):115-24. PubMed ID: 22148909
[TBL] [Abstract][Full Text] [Related]
22. Soy germ extract alleviates menopausal hot flushes: placebo-controlled double-blind trial.
Imhof M; Gocan A; Imhof M; Schmidt M
Eur J Clin Nutr; 2018 Jul; 72(7):961-970. PubMed ID: 29849181
[TBL] [Abstract][Full Text] [Related]
23. Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms.
Umland EM
J Manag Care Pharm; 2008 Apr; 14(3 Suppl):14-9. PubMed ID: 18439062
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of isoflavones in relieving vasomotor menopausal symptoms - A systematic review.
Jacobs A; Wegewitz U; Sommerfeld C; Grossklaus R; Lampen A
Mol Nutr Food Res; 2009 Sep; 53(9):1084-97. PubMed ID: 19653225
[TBL] [Abstract][Full Text] [Related]
25. A critical appraisal of vasomotor symptom assessment tools used in clinical trials evaluating hormone therapy compared to placebo.
Christakis MK; Strobino DM; Shen W
Menopause; 2019 Nov; 26(11):1334-1341. PubMed ID: 31567867
[TBL] [Abstract][Full Text] [Related]
26. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study.
Upmalis DH; Lobo R; Bradley L; Warren M; Cone FL; Lamia CA
Menopause; 2000; 7(4):236-42. PubMed ID: 10914616
[TBL] [Abstract][Full Text] [Related]
27. Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women.
Khaodhiar L; Ricciotti HA; Li L; Pan W; Schickel M; Zhou J; Blackburn GL
Menopause; 2008; 15(1):125-32. PubMed ID: 18257146
[TBL] [Abstract][Full Text] [Related]
28. Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety.
Archer DF; Dupont CM; Constantine GD; Pickar JH; Olivier S;
Am J Obstet Gynecol; 2009 Mar; 200(3):238.e1-238.e10. PubMed ID: 19167693
[TBL] [Abstract][Full Text] [Related]
29. The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study.
Hidalgo LA; Chedraui PA; Morocho N; Ross S; San Miguel G
Gynecol Endocrinol; 2005 Nov; 21(5):257-64. PubMed ID: 16373244
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of fezolinetant for moderate to severe vasomotor symptoms associated with menopause among women in East Asia: a phase 3 randomized study (MOONLIGHT I).
Ruan X; Bai W; Ren M; Kim T; Lee JY; Chuang FC; Wang PH; He W; Ma X; Miyazaki K; Song N; Wang X; Yu Q
J Int Med Res; 2024 May; 52(5):3000605241247684. PubMed ID: 38818888
[TBL] [Abstract][Full Text] [Related]
31. Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms.
Ferrari A
J Obstet Gynaecol Res; 2009 Dec; 35(6):1083-90. PubMed ID: 20025635
[TBL] [Abstract][Full Text] [Related]
32. Body mass index and menopausal disorders during menopause affect vasomotor symptoms of postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes.
Tane K; Egawa C; Takao S; Yamagami K; Miyashita M; Baba M; Ichii S; Konishi M; Kikawa Y; Minohata J; Okuno T; Miyauchi K; Wakita K; Suwa H; Hashimoto T; Nishino M; Matsumoto T; Hidaka T; Konishi Y; Sakoda Y; Miya A; Kishimoto M; Nishikawa H; Kono S; Kokufu I; Sakita I; Kitatsuji K; Oh K; Akazawa K; Miyoshi Y
Breast Cancer; 2017 Jul; 24(4):528-534. PubMed ID: 27730528
[TBL] [Abstract][Full Text] [Related]
33. Consumption of a soy drink has no effect on cognitive function but may alleviate vasomotor symptoms in post-menopausal women; a randomised trial.
Furlong ON; Parr HJ; Hodge SJ; Slevin MM; Simpson EE; McSorley EM; McCormack JM; Magee PJ
Eur J Nutr; 2020 Mar; 59(2):755-766. PubMed ID: 30863894
[TBL] [Abstract][Full Text] [Related]
34. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials.
Taku K; Melby MK; Kronenberg F; Kurzer MS; Messina M
Menopause; 2012 Jul; 19(7):776-90. PubMed ID: 22433977
[TBL] [Abstract][Full Text] [Related]
35. The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial.
Carmignani LO; Pedro AO; Costa-Paiva LH; Pinto-Neto AM
Maturitas; 2010 Nov; 67(3):262-9. PubMed ID: 20833488
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of soyfoods and soybean isoflavone supplements for alleviating menopausal symptoms is positively related to initial hot flush frequency.
Messina M; Hughes C
J Med Food; 2003; 6(1):1-11. PubMed ID: 12804015
[TBL] [Abstract][Full Text] [Related]
37. Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Vasomotor Symptoms in the Selective Estrogens, Menopause, and Response to Therapy Trials.
Archer DF; Freeman EW; Komm BS; Ryan KA; Yu CR; Mirkin S; Pinkerton JV
J Womens Health (Larchmt); 2016 Nov; 25(11):1102-1111. PubMed ID: 27676118
[TBL] [Abstract][Full Text] [Related]
38. Effect of omega-3 supplements on vasomotor symptoms in menopausal women: A systematic review and meta-analysis.
Mohammady M; Janani L; Jahanfar S; Mousavi MS
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():295-302. PubMed ID: 30056356
[TBL] [Abstract][Full Text] [Related]
39. Ospemifene's effect on vasomotor symptoms: a post hoc analysis of phase 2 and 3 clinical data.
Constantine GD; Archer DF; Pollycove R; Jiang W; Altomare C; Pinkerton JV
Menopause; 2016 Sep; 23(9):957-64. PubMed ID: 27404027
[TBL] [Abstract][Full Text] [Related]
40. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
Gordon S; Walsh BW; Ciaccia AV; Siddhanti S; Rosen AS; Plouffe L
Obstet Gynecol; 2004 Feb; 103(2):267-73. PubMed ID: 14754694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
